Keryn Christiansen ASA Research Award

Stay tuned for the 2025 Keryn Christiansen ASA Research Award.

The 2024 Australian Society for Antimicrobials (ASA) Annual Research Grant of up to $25,000 to support original research is now available.
The following conditions apply:

  • Funding is limited to ASA financial members.
  • The Principal Investigator (PI) must have been an ASA member for at least twelve month
  • Preference will be given to stand-alone projects
  • Preference will be given to early-career researchers
  • The successful applicant will present their work at an ASA annual scientific meeting
  • If applicable, the PI will submit an article for the ASA newsletter and website
  • ASA will be acknowledged in all resulting publications and presentations
  • 12 and 24 month progress reports must be submitted to the ASA committee

The research funds are to be used for the project, as per the budget application only. ASA does not support an institution’s infrastructure or overhead costs.
The application must be performed online via the ASA website Research Grant Application Form and must include:

  • A copy of the PI’s CV.
  • Head of Department confirmation of the application and the Department has the resources required to undertake the project.

The grant application and CV will be assessed by a panel of at least six independent reviewers using a standardised scoring system. Applicants will be informed of the decision one week before the ASA annual scientific meeting “Antimicrobials 2024”.
Applications will be accepted online up to 30 October 2023.

Click here for the Research Grant Application Form.
For further enquiries please contact the ASA secretary on

ASA Antimicrobials 2024 Research Grant Recipient

Sewunet Belachew

The University of Queensland, QLD

“Investigating Antimicrobial use in Aboriginal and Torres Strait Islander Queenslanders with Cancer Diagnosis: Insights for Effective Antimicrobial Stewardship”

ASA Antimicrobials 2023 Research Grant Recipient

Kelly Cairns

The Alfred Hospital and Monash University, VIC

“Vanguard Randomised Controlled Trial of Daptomycin Therapeutic Drug Monitoring for Vancomycin Resistant Enterococcus faecium Bloodstream Infections”

ASA Antimicrobials 2022 Research Grant Recipient

Dr Iain J. Abbott

ICPMR The Alfred Hospital and Monash University, VIC

“Optimising antimicrobial therapy to treat problematic biofilms using a novel
pharmacodynamic urinary catheter biofilm model”

ASA Antimicrobials 2020 Research Grant Recipient

Dr Caitlin Keighley

ICPMR Westmead Hospital, NSW

Genomics of Antimicrobial resistance in Candida tropicalis

ASA Antimicrobials 2019 Research Grant Recipient

Kelly Wyres

Monash University, VIC

Understanding the Risks of Emergence of Last Line Drug Resistance in Distinct Strains of Klebsiella pneumoniae

ASA Antimicrobials 2018 Research Grant Recipient

Shakeel Mowlaboccus

University of Western Australia, WA

Molecular mechanism of reduced susceptibility to ceftriaxone and penicillin in Neisseria meningitidis

ASA Antimicrobials 2017 Research Grant Recipient

Dr Christopher Blyth

University of Western Australia, WA

Invasive Staphylococcus aureus Infections and Hospitalisations (ISAIAH) in Australian Children: A Two-year Prospective, Multi-Centre Cohort Examining Contemporary Paediatric Clinical and Molecular Epidemiology of S. aureus

ASA Antimicrobials 2016 Research Grant Recipient

Norelle Sherry and Jason Kwong

University of Melbourne

Genomic Investigation of Carbapenem-resistant Enterobacteriacae in Victoria

ASA Antimicrobials 2014 Research Grant Recipient

Justine Gibson

University of Queensland

Promiscuous plasmids in avian pathogenic (APEC) and faecal Escherichia coli (AFEC): How to safeguard Australia

ASA Antimicrobials 2013 Research Grant Recipient

David Paterson

University of Queensland 

Randomised Controlled Trial of Meropenem versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections due to Ceftriaone Non-Susceptible Escherichia coli and Klebsiella spp

ASA Antimicrobials 2012 Research Grant Recipient

Sally Partridge

Westmead Hospital

Complete Sequencing of Selected, Informative Multi-Resistance Plasmids from Enterobacteriaceae Clinical isolates